ECE 2022
The debate about pituitary adenoma vs. PitNET
www.high5endocrinology.tv | Meeting coverage | ECE 2022
ECE 2022
The debate about pituitary adenoma vs. PitNET
ECE 2022
Real-life data on osilodrostat
ECE 2022
New development on hyperaldosteronism
ECE 2022
MRI controls after pituitary surgery without gadolinium
ECE 2022
Diabetes insipidus - the patient's perspective
ECE 2022
News about high-dose cabergoline in prolactinoma…
ECE 2022
Muscles and aging
ECE 2022
Anti-aging with bisphosphonates?
ECE 2022
Update on calcium metabolism disorders - PARAT
ECE 2022
Aggressive pituitary tumors / pituitary carcinomas
ECE 2022
Malignant pheocromocytomas
ECE 2022
Differences in brain morphs and function in individuals…
ECE 2022
Old dogmas and new players in puberty and reproduction
ECE 2022
PCOS - genetic or epigenetic?
ECE 2022
Transition from childhood to adolescence
ECE 2022
Kisspeptin in men with low sexual desires
ECE 2022
MKRN3 and puberty regulation
ECE 2022
Obesity - are we up to date?
ECE 2022
Long-term treatment with GLP-1 agonists
ECE 2022
Iron and the thyroid
ECE 2022
Endocrine disruptors - the maternal behavior and…
Für den erfolgreichen Abschluss der Fortbildungsmodule ist die korrekte (mind. 70%) Beantwortung der Lernerfolgskontrolle für das jeweilige Modul verpflichtend.
Jetzt gleich den Fragebogen ausfüllen!